Herman H. Vandenburgh
Corporate Officer/Principal bei Brown University
Profil
Herman H.
Vandenburgh was the founder of Myomics, Inc. (founded in 2003) where he held the title of Chief Executive Officer from 2010 to 2011, and Cell Based Delivery, Inc. (founded in 2001) where he held the title of Chief Scientific Officer in 2003.
Currently, he is a Professor at Brown University since 1981.
He previously worked as a Principal at the National Institutes of Health.
Dr. Vandenburgh earned a doctorate degree from the University of Pennsylvania.
Aktive Positionen von Herman H. Vandenburgh
Unternehmen | Position | Beginn |
---|---|---|
Brown University | Corporate Officer/Principal | 21.04.2011 |
Ehemalige bekannte Positionen von Herman H. Vandenburgh
Unternehmen | Position | Ende |
---|---|---|
Cell Based Delivery, Inc. | Gründer | 01.01.2003 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
Myomics, Inc.
Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Vorstandsvorsitzender | - |
Ausbildung von Herman H. Vandenburgh
University of Pennsylvania | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Myomics, Inc.
Myomics, Inc. Pharmaceuticals: GenericHealth Technology Myomics, Inc. developed drugs to treat neuromuscular disease indications, such as muscle atrophy in the elderly and muscle wasting in chronic illness, included cancer and muscular dystrophy disorders. It had discovery programs based on its two proprietary technology platforms: tissue-engineered muscle, which can be generated in vitro from human and animal models of normal and diseased muscle, and opto-mechanical systems to monitor the ability of candidate compounds to increase the contractile strength of tissue-engineered muscle. The company was founded in 2003 and headquartered in Providence, RI. | Health Technology |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Cell Based Delivery, Inc. |